Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - BIOHITECH GLOBAL, INC. | tv501004_8k.htm |
Exhibit 99.1
| BIOHITECH GLOBAL, Inc. | |
| 80 Red Schoolhouse Road, Suite 101 | |
|
Chestnut Ridge, NY 10977 | |
BioHiTech Global Reports Second Quarter 2018 Financial Results
Q2 2018 revenues increase by 65.5% with gross profit increasing by 185.4%
CHESTNUT RIDGE, NY – August 15, 2018 – BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a technology and services company that provides cost-effective and sustainable waste management solutions, reported financial results for the second quarter ended June 30, 2018.
Business Highlights
| · | Launched a New Bundled Sustainable Disposal Services Offering with Gold Medal Group Driven by BioHiTech Technology - The Company and Gold Medal, Group, LLC, a market leader in municipal, commercial, and industrial solid waste collection in the Philadelphia, Southern New Jersey, Maryland and West Virginia markets, teamed up to provide Temple University with Gold Medal's traditional disposal services in combination with BioHiTech's food waste digesters and supply chain data analytics platform designed to help reduce waste generation for one all-inclusive monthly service charge. Gold Medal has begun marketing the bundled monthly services offering to customers as a way to help its customers reduce disposal costs while having a positive impact on the environment. Both companies see a significant opportunity in this new technology driven sustainable services offering. |
| · | Received Patent for Networked Weight Tracking System - The Company received a patent from the U.S. Patent and Trademark Office for its food waste weight tracking system and method using a waste disposal machine with data network connectivity to transmit weight tracking system information over a computer network, or cloud, for storage, tracking aggregation and sharing by a centralized computer system. The Company sees this patent as a major competitive advantage for BioHiTech by making it the only company to have an integrated solution to measure food waste volumes directly from any PLC controlled food waste disposal device, and share that data for analysis immediately via any network or the cloud. |
| · | Selected as a Pre-Approved Supplier of Food Waste Digesters for a Major International Hotel Chain - Upon being selected as a pre-approved supplier, the Company has begun its initial marketing efforts for its Revolution Series and Eco-Safe Digesters equipped with its proprietary supply chain data analytics software to the more than 150 individual hotel properties located throughout the UK. BioHiTech received orders from several UK properties for a total of six digesters for delivery in Q2 2018 and expects to deliver a minimum of 20 units in 2018. |
| · | Completed Uplisting of Its Common Stock to the Nasdaq Capital Market and Added to the Russell Microcap® Index – BioHiTech’s common stock commenced trading on The Nasdaq Capital Market in April 2018 and was added to the Russell Microcap Index in June. The Company sees both events helping to increase corporate visibility in the financial marketplace and broaden its shareholder base |
Frank E. Celli, CEO of BioHiTech, commented, "We continue to make progress in numerous aspects of our strategic plan to build value for our stockholders. As our Revolution Series Digesters gain traction in the marketplace, we achieved significant quarter over quarter revenue growth in our digester business as well as a further expansion of our sales pipeline. We also made significant progress in our HEBioT development plans in New York State where we are currently in the permitting process.”
Mr. Celli continued, “Our business partnership with Gold Medal Group has added a significant management services revenue stream while enabling us to begin to demonstrate the true value of our technology to the traditional waste management industry. We believe that as we rollout this new bundled services platform with Gold Medal it will clearly show how a combination of traditional services and BioHiTech technology will enhance waste management profitability while reducing customer costs and environmental impact. When our first co-owned HEBioT facility is commissioned in West Virginia later this year, we can combine those technologies with traditional service to cost-effectively divert more than 90% of mixed waste from landfills in certain market with a roadmap to expand that footprint throughout the Northeastern US in the coming years. As we move through the second half of 2018, we will continue to execute on our plan to grow revenue and expand our business for the benefit of our stockholders while effecting positive change in the waste management industry that is good for the customer and beneficial for the environment.”
Q2 Financial Highlights
Revenue: Revenues in Q2 2018 were $909,000, a 65.5% increase compared to revenues of $549,000 in Q2 2017. Recurring revenue from rental, services and maintenance grew by 25.1% to reach $458,000 or 50.5% of total revenue. The increase in rental, service and maintenance is primarily the result of a larger overall number of deployed units. Revenue from equipment sales grew by 9.4% to $200,000. The Company continues to focus more of its resources on its rental model and therefore expects equipment sales to vary based upon reseller activity predominantly in overseas markets. Recurring revenue from management advisory fees related to its new management services contract with Gold Medal in 2018 totaled $251,000. The Company expects that revenue stream to increase over time as Gold Medal expands its business in the coming years.
Gross Profit: Q2 2018 gross profit increased by 185.4% to $485,000 compared to $170,000 in Q2 2017. Gross profit margin increased by 23.4 percentage points to reach 53.3%. The increase in gross margin was driven by 100% margin from management advisory fees as the Company is providing the services with its existing management team without incurring any additional variable costs as part its mission to cost effectively reduce the environmental impact of waste management services. Rental, service and maintenance gross margin increased by 11.4 percentage points to 37.0%, primarily as the Company achieved improved economies of scale. The aforementioned improvements in gross margin were partially offset by a 9.4 percentage point decline in gross margin from equipment sales.
Operating Expenses: Q2 2018 operating expenses increased by $49,000 or 2.9% to $1.72 million compared to $1.67 million in Q2 2017. The increase in operating expenses was mainly due to a $84,000 foreign exchange expense in Q2 2018 compared to a foreign currency gain of $35,000 in Q2 2017 as well as increases in sales and marketing expenses, personnel costs, and fees associated with the Nasdaq uplisting in April. The increase in these expenses was largely offset by a $195,000 decrease in professional fees primarily related to marketing and investor relations and a $22,000 decrease in R&D expense.
Operating Loss: Q2 2018 operating loss narrowed to $(1.2) million compared to $(1.5) million in Q2 2017. The improvement in the operating result was due to a $315,000 increase gross profit partially offset by a $49,000 increase in operating expenses in the comparable periods.
Net Loss: The Company recorded a Q2 2018 net loss of $(5.5) million or $(0.39) on 14.2 million shares versus a net loss of ($1.9) million or $(0.23) on 8.3 million shares in Q2 2017. The increase in net loss was attributable to a $3.5 million non-cash interest expense recorded in Q2 2018 related to the valuation of certain warrants outstanding upon the conversion of associated debt into common stock, a $237,000 increase in interest expense, and $141,000 loss related to the accounting treatment of its investment in the acquisition of Gold Medal Group.
Select Balance Sheet Items: The Company had cash and cash equivalents of $1.1 million with shareholder equity of $4.2 million as of June 30, 2018 compared to cash and cash equivalents of $901,000 and a shareholder deficit of ($11.0) million as of December 31, 2017.
Brian C. Essman, CFO commented, "During the quarter we completed a significant transformation of our balance sheet through our move to the Nasdaq Capital Market. Upon that event, the majority of our then outstanding debt automatically converted into equity. When coupled with debt conversions and equity transactions that took place in Q1 2018, we achieved a $15.3 million improvement in shareholder equity compared to December 31, 2017. We also continued to build recurring revenue from our digester business and our high margin management services agreement with Gold Medal. With a much stronger balance sheet and growing momentum in our industry for sustainable waste disposal solutions, we are now well positioned to achieve continued growth in our cost-effective food waste disposal business and lay the foundation for the near term commercialization of our HEBioT MBT business. We are committed to the execution of our long-term growth plans as we work diligently to build significant value for the benefit of our stockholders for years to come."
Additional information can be found in the Company's Form 10-Q filed with the United States Securities and Exchange Commission on August 14, 2018.
About BioHiTech Global
BioHiTech Global, Inc. (NASDAQ: BHTG), is changing the way we think about managing waste. Our innovative waste management services combined with our disruptive technologies provide sustainable waste disposal and supply chain management solutions for businesses and municipalities of all sizes. Our technology platform, including the on and off-site biological treatment of waste, is designed to reduce overall waste generation and virtually eliminate landfill usage while creating a valuable renewable fuel. For more information, please visit www.biohitech.com.
Forward Looking Statements
Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance. These statements may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of BioHiTech Global, Inc. to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. BioHiTech Global, Inc. assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as “Risk Factors” in our filings with the Securities and Exchange Commission (“SEC”). There may be other factors not mentioned above or included in the BioHiTech’s SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. BioHiTech Global, Inc. assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.
Company Contact:
BioHiTech Global, Inc.
Rich Galterio
Executive Vice President
Direct: 845.367.0603
rgalterio@biohitech.com
www.biohitech.com
BioHiTech Global, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
| 2018 | 2017 | 2018 | 2017 | |||||||||||||
| Revenue | ||||||||||||||||
| Rental, service and maintenance | $ | 458,843 | $ | 366,812 | $ | 899,336 | $ | 725,348 | ||||||||
| Equipment sales | 199,638 | 182,405 | 265,488 | 414,549 | ||||||||||||
| Management advisory and other fees | 250,656 | - | 390,039 | - | ||||||||||||
| Total revenue | 909,137 | 549,217 | 1,554,863 | 1,139,897 | ||||||||||||
| Cost of revenue | ||||||||||||||||
| Rental, service and maintenance | 289,015 | 272,757 | 587,584 | 531,697 | ||||||||||||
| Equipment sales | 135,564 | 106,664 | 199,504 | 239,154 | ||||||||||||
| Total Cost of revenue | 424,579 | 379,421 | 787,088 | 770,851 | ||||||||||||
| Gross profit | 484,558 | 169,796 | 767,775 | 369,046 | ||||||||||||
| Operating expenses | ||||||||||||||||
| Selling, general and administrative | 1,323,194 | 1,057,223 | 2,414,766 | 2,121,852 | ||||||||||||
| Research and development | 195,130 | 216,822 | 396,686 | 404,324 | ||||||||||||
| Professional fees | 169,154 | 364,227 | 456,016 | 1,013,850 | ||||||||||||
| Depreciation and amortization | 28,148 | 28,335 | 58,864 | 58,107 | ||||||||||||
| Total operating expenses | 1,715,626 | 1,666,607 | 3,326,332 | 3,598,133 | ||||||||||||
| Loss from operations | (1,231,068 | ) | (1,496,811 | ) | (2,558,557 | ) | (3,229,087 | ) | ||||||||
| Other expense (income) | ||||||||||||||||
| Equity loss in affiliate | 147,077 | 5,916 | 192,490 | 5,916 | ||||||||||||
| Interest expense | 611,801 | 374,175 | 1,166,077 | 670,432 | ||||||||||||
| Interest expense incurred in warrant valuation and conversions | 3,506,027 | 1,999 | 6,799,640 | 1,999 | ||||||||||||
| Total other expense | 4,264,905 | 382,090 | 8,158,207 | 678,347 | ||||||||||||
| Net loss | (5,495,973 | ) | (1,878,901 | ) | (10,716,764 | ) | (3,907,434 | ) | ||||||||
| Other comprehensive (loss) income | ||||||||||||||||
| Foreign currency translation adjustment | 57,362 | (21,340 | ) | 23,920 | (28,504 | ) | ||||||||||
| Comprehensive loss | $ | (5,438,611 | ) | $ | (1,900,241 | ) | $ | (10,692,844 | ) | $ | (3,935,938 | ) | ||||
| Net loss per common share - basic and diluted | $ | (0.39 | ) | $ | (0.23 | ) | $ | (0.85 | ) | $ | (0.47 | ) | ||||
| Weighted average number of common shares outstanding - basic and diluted | 14,216,404 | 8,322,086 | 12,587,344 | 8,276,154 | ||||||||||||
BioHiTech Global, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (Unaudited)
| June 30, | December 31, | |||||||
| 2018 | 2017 | |||||||
| (Revised) | ||||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash | $ | 1,053,028 | $ | 901,112 | ||||
| Accounts receivable, net | 393,835 | 274,405 | ||||||
| Inventory | 708,138 | 332,101 | ||||||
| Prepaid expenses and other current assets | 138,038 | 79,686 | ||||||
| Total Current Assets | 2,293,039 | 1,587,304 | ||||||
| Equipment on operating leases, net | 1,614,627 | 1,451,144 | ||||||
| Equipment, fixtures and vehicles, net | 55,730 | 63,509 | ||||||
| Intangible assets, net | 129,032 | 174,133 | ||||||
| Investment in unconsolidated affiliates | 3,073,773 | 1,016,263 | ||||||
| MBT facility development and license costs | 6,457,180 | 6,223,766 | ||||||
| Other assets | 13,500 | 23,500 | ||||||
| Total Assets | $ | 13,636,881 | $ | 10,539,619 | ||||
| Liabilities and Stockholders' Equity (Deficit) | ||||||||
| Current Liabilities: | ||||||||
| Line of credit | $ | 976,112 | $ | 1,000,000 | ||||
| Accounts payable | 1,110,039 | 1,287,740 | ||||||
| Accrued interest payable | 114,925 | 29,431 | ||||||
| Accrued expenses | 445,731 | 892,136 | ||||||
| Deferred revenue | 114,779 | 84,686 | ||||||
| Customer deposits | 7,134 | 39,498 | ||||||
| Long-term debt, current portion | 9,018 | 8,874 | ||||||
| Total Current Liabilities | 2,777,738 | 3,342,365 | ||||||
| Notes payable | 100,000 | 375,000 | ||||||
| Line of credit | - | 1,463,736 | ||||||
| Junior note due to related party, net of discounts of $128,850 as of June 30, 2018 | 915,627 | 4,500,000 | ||||||
| Advance from related party | - | 544,777 | ||||||
| Accrued interest | 1,151,668 | 1,860,591 | ||||||
| Convertible unsecured note | - | 103,885 | ||||||
| Convertible subordinated secured notes | - | 1,021,916 | ||||||
| Unsecured subordinated mandatorily convertible series notes | - | 7,698,819 | ||||||
| Senior Secured Note Payable, net of financing costs of $182,075 and discounts of $1,112,510 | 3,705,415 | - | ||||||
| Long-term debt, net of current portion | 17,425 | 21,971 | ||||||
| Total Liabilities | 8,667,873 | 20,933,060 | ||||||
| Series A redeemable convertible preferred stock, 333,401 shares designated and issued, and 230,001 and 333,401 outstanding as of June 30, 2018 and December 31, 2017 | 722,216 | 623,283 | ||||||
| Commitments and Contingencies | - | - | ||||||
| Stockholders' Equity (Deficit) | ||||||||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; 2,444,601 and 1,444,601 designated, 1,189,234 and 493,401 issued, and 657,501 and 493,401 outstanding as of June 30, 2018 and December 31, 2017, respectively: | ||||||||
| Series B Convertible preferred stock, 1,111,200 shares designated: 428,333 and 160,000 shares issued, and 0 and 160,000 outstanding as of June 30, 2018 and December 31, 2017, respectively | - | 699,332 | ||||||
| Series C Convertible preferred stock, 1,000,000 shares designated, 427,500 shares issued and outstanding | 3,050,142 | - | ||||||
| Common stock, $0.0001 par value, 50,000,000 shares authorized, 14,531,152 and 9,598,208 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively, at par | 1,453 | 960 | ||||||
| Additional paid in capital | 41,593,223 | 17,752,990 | ||||||
| Accumulated deficit | (40,383,356 | ) | (29,431,416 | ) | ||||
| Accumulated other comprehensive (loss) | (14,670 | ) | (38,590 | ) | ||||
| Total Stockholders' Equity (Deficit) | 4,246,792 | (11,016,724 | ) | |||||
| Total Liabilities and Stockholders' Equity (Deficit) | $ | 13,636,881 | $ | 10,539,619 | ||||
BioHiTech Global, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Six Months Ended June 30, | ||||||||
| 2018 | 2017 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss: | $ | (10,716,764 | ) | $ | (3,907,434 | ) | ||
| Adjustments to reconcile net loss to net cash used in operations: | ||||||||
| Depreciation and amortization | 231,120 | 202,064 | ||||||
| Provision for bad debts | 21,355 | 29,212 | ||||||
| Stock based employee compensation | 154,913 | 230,981 | ||||||
| Fees paid in stock and warrants | - | 518,267 | ||||||
| Interest resulting from amortization of financing costs and discounts | 911,456 | 71,903 | ||||||
| Equity loss in affiliate | 192,490 | 5,916 | ||||||
| Change in fair value of warrant liability | - | 1,999 | ||||||
| Interest resulting from warrants valued upon conversion of host debt instruments | 6,424,970 | - | ||||||
| Changes in operating assets and liabilities | (969,679 | ) | 693,725 | |||||
| Net cash used in operations | (3,750,139 | ) | (2,153,367 | ) | ||||
| Cash flow from investing activities: | ||||||||
| Sale of used machinery and equipment | - | 13,352 | ||||||
| Investment in Entsorga West Virginia, LLC | - | (1,034,027 | ) | |||||
| MBT facility development costs incurred | (233,413 | ) | (74,966 | ) | ||||
| Purchases of equipment, fixtures and vehicles | (6,059 | ) | (4,040 | ) | ||||
| Net cash used in investing activities | (239,472 | ) | (1,099,681 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Proceeds from issuance of senior secured credit facility and common stock | 5,000,000 | - | ||||||
| Repayment of line of credit facility | (2,463,736 | ) | - | |||||
| Proceeds from new line of credit facility | 1,000,000 | - | ||||||
| Proceeds from convertible notes, including warrants and beneficial conversion features | - | 620,000 | ||||||
| Deferred financing costs incurred | (237,187 | ) | (16,000 | ) | ||||
| Repayments of long-term debt | (4,402 | ) | (4,228 | ) | ||||
| Proceeds from the issuance of Series B convertible preferred stock and warrants | ||||||||
| Redemption of Series A preferred stock | (317,000 | ) | - | |||||
| Related party: | 1,125,000 | |||||||
| Net increases of advances | - | 1,169,527 | ||||||
| Proceeds from promissory notes | - | 786,973 | ||||||
| Proceeds from convertible notes | - | 500,000 | ||||||
| Net cash provided by financing activities | 4,102,675 | 3,056,272 | ||||||
| Effect of exchange rate on cash | 38,852 | 21,246 | ||||||
| Net change in cash | 151,916 | (175,530 | ) | |||||
| Cash - beginning of period | 901,112 | 325,987 | ||||||
| Cash - end of period | $ | 1,053,028 | $ | 150,457 | ||||